【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 11
1.1 List of Tables 17
1.2 List of Figures 23
2 Introduction 25
2.1 Catalyst 25
2.2 Related Reports 26
2.3 Upcoming Related Reports 27
3 Disease Overview 28
3.1 Etiology 28
3.1.1 MRSA Strains 31
3.1.2 VISA Strains 33
3.1.3 VRSA Strains 33
3.2 Pathophysiology 34
3.2.1 Infection Sites 34
3.2.2 Expression of Virulence Factors 36
3.2.3 Mechanisms of Antibiotic Resistance 38
3.2.4 Biofilm Formation 42
3.3 Symptoms 43
3.4 Prognosis 44
3.4.1 Skin and Soft Tissue Infections 45
3.4.2 Pneumonia 45
3.4.3 Bacteremia 45
3.4.4 Chronic MRSA Infection 46
4 Epidemiology 47
4.1 Disease Background 47
4.2 Risk Factors and Comorbidities 48
4.3 Global Trends 50
4.3.1 US 50
4.3.2 5EU 51
4.3.3 Japan 51
4.4 Forecast Methodology 52
4.4.1 Sources Used 54
4.4.2 Sources Not Used 67
4.4.3 Forecast Assumptions and Methods 68
4.5 Epidemiological Forecast for MRSA (2014-2024) 74
4.5.1 Hospitalized Incident Cases of MRSA 74
4.5.2 Sex-Specific Hospitalized Incident Cases of MRSA 76
4.5.3 Age-Specific Hospitalized Incident Cases of MRSA 78
4.5.4 Age-Standardized Hospitalized Incidence Rate of MRSA 80
4.5.5 Proportion of Hospitalized Incident MRSA Cases by Infection Site 82
4.5.6 Proportion of Hospitalized Incident MRSA Cases by Case Definition 83
4.6 Discussion 84
4.6.1 Epidemiological Forecast Insight 84
4.6.2 Limitations of the Analysis 85
4.6.3 Strengths of the Analysis 86
5 Disease Management 87
5.1 Diagnosis and Treatment Overview 87
5.1.1 Diagnosis 87
5.1.2 Treatment Guidelines 88
5.1.3 Clinical Practice 89
5.2 US 91
5.3 5EU 95
5.4 Japan 98
6 Competitive Assessment 102
6.1 Overview 102
6.2 Product Profiles – Glycopeptides and Lipoglycopeptides 107
6.2.1 Vancomycin 107
6.2.2 Dalvance (dalbavancin) 115
6.2.3 Orbactiv (oritavancin) 124
6.2.4 Vibativ (telavancin) 132
6.2.5 Targocid (teicoplanin) 142
6.3 Product Profiles – Lipopeptides 148
6.3.1 Cubicin (daptomycin) 148
6.4 Product Profiles – Oxazolidinones 157
6.4.1 Zyvox (linezolid) 157
6.4.2 Sivextro (tedizolid phosphate) 169
6.5 Product Profiles – Cephalosporins 178
6.5.1 Teflaro (ceftaroline fosamil) 178
6.5.2 Zevtera (ceftobiprole medocaril) 188
6.6 Product Profiles – Glycylcyclines 197
6.6.1 Tygacil (tigecycline) 197
6.7 Other Antimicrobial Agents 204
7 Unmet Need and Opportunity Analysis 206
7.1 Overview 206
7.2 Drugs with Demonstrated Efficacy in Difficult-to-Treat Patient Populations 209
7.2.1 Unmet Need 209
7.2.2 Gap Analysis 211
7.2.3 Opportunity 212
7.3 Expand Breadth of Clinical Data Outside of Skin Infections 213
7.3.1 Unmet Need 213
7.3.2 Gap Analysis 214
7.3.3 Opportunity 215
7.4 Physician Education 215
7.4.1 Unmet Need 215
7.4.2 Gap Analysis 216
7.4.3 Opportunity 217
7.5 Antibiotics with More Convenient Formulations and Dosing Schedules 218
7.5.1 Unmet Need 218
7.5.2 Gap Analysis 220
7.5.3 Opportunity 221
7.6 Innovative Approaches to Clinical Trial Design 222
7.6.1 Unmet Need 222
7.6.2 Gap Analysis 223
7.6.3 Opportunity 224
7.7 Drugs with Novel Mechanisms of Action 227
7.7.1 Unmet Need 227
7.7.2 Gap Analysis 228
7.7.3 Opportunity 228
7.8 More Affordable Therapies 229
7.8.1 Unmet Need 229
7.8.2 Gap Analysis 230
7.8.3 Opportunity 230
8 Pipeline Assessment 233
8.1 Overview 233
8.2 Promising Drugs in Late-Stage Clinical Development 233
8.2.1 Delafloxacin (RX-3341) 236
8.2.2 Solithromycin (CEM-101) 243
8.2.3 Omadacycline (PTK-0796) 250
8.2.4 KRP-AM1977X 257
8.2.5 Taksta (fusidic acid, oral tablets) 263
8.2.6 Lefamulin (BC-3781) 268
8.2.7 Debio1450 (Debio1452 prodrug) 276
8.2.8 Brilacidin 282
8.3 Other Promising Products in Clinical Development 289
9 Current and Future Players 291
9.1 Overview 291
9.2 Trends in Corporate Strategy 294
9.3 Company Profiles – Current Players 296
9.3.1 Pfizer 296
9.3.2 Merck 298
9.3.3 Allergan 299
9.3.4 The Medicines Company 301
9.3.5 Theravance Biopharma 303
9.3.6 Basilea Pharmaceutica 305
9.3.7 Sanofi 306
9.4 Additional Companies with Promising Pipeline Products 307
9.4.1 Melinta Therapeutics 307
9.4.2 Cempra Pharmaceuticals 308
9.4.3 Paratek Pharmaceuticals 309
9.4.4 Kyorin Pharmaceutical 310
9.4.5 Nabriva Therapeutics 310
9.4.6 Debiopharm International 311
9.4.7 Cellceutix Corporation 311
10 Market Outlook 313
10.1 Global Markets 313
10.1.1 Forecast 313
10.1.2 Drivers and Barriers – Global Issues 321
10.2 US 322
10.2.1 Forecast 322
10.2.2 Key Events 327
10.2.3 Drivers and Barriers 328
10.3 5EU 329
10.3.1 Forecast 329
10.3.2 Key Events 334
10.3.3 Drivers and Barriers 335
10.4 Japan 336
10.4.1 Forecast 336
10.4.2 Key Events 341
10.4.3 Drivers and Barriers 342
11 Appendix 343
11.1 Bibliography 343
11.2 Abbreviations 394
11.3 Methodology 400
11.4 Forecasting Methodology 400
11.4.1 Hospitalized MRSA Patients 400
11.4.2 Percentage of Drug-Treated MRSA Patients 400
11.4.3 Drugs Included in Each Therapeutic Class 401
11.4.4 Launch, Label Expansion, and Patent Expiry Dates 402
11.4.5 General Pricing Assumptions 404
11.4.6 Individual Drug Assumptions 406
11.4.7 Generic Erosion 418
11.4.8 Pricing of Pipeline Agents 418
11.5 Primary Research – KOLs Interviewed for This Report 420
11.6 Primary Research – Prescriber Survey 422
11.7 About the Authors 423
11.7.1 Author and Therapy Area Director 423
11.7.2 Author 423
11.7.3 Epidemiologist 424
11.7.4 Global Director of Therapy Analysis and Epidemiology 424
11.7.5 Global Head of Healthcare 425
11.8 About GlobalData 426
11.9 Disclaimer 426
【レポート販売概要】
■ タイトル:メチシリン耐性黄色ブドウ球菌(MRSA)感染症治療薬の世界市場予測・分析■ 英文:PharmaPoint: Methicillin-Resistant Staphylococcus Aureus (MRSA) - Global Drug Forecast and Market Analysis to 2024
■ 発行日:2015年12月
■ 調査会社:GlobalData
■ 商品コード:GDHC108PIDR
■ 調査対象地域:グローバル
- 世界の遺伝子検査市場(2012- 2016)TechNavio's analysts forecast the Global Genetic Testing market to grow at a CAGR of 9.45 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing global aging population. The Global Genetic Testing market has also been witnessing the increasing availability of Direct to Consumer (DTC) tests. However, the absence of credible standard procedures …
- 企業向けアプリケーション市場:技術及び市場動向Summary Enterprise applications continue to form the backbone of most organizations' enterprise infrastructure. Enterprise applications have come a long way, from being an on-premise standalone solution to becoming mobility and cloud computing enabled enterprise applications that are often closely integrated with other business applications. Furthermore, global customers and the need for widesprea …
- 心的外傷後ストレス障害(Post-Traumatic Stress Disorder (PTSD))の治療薬パイプライン動向(2015年上半期版)Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2015’, provides an overview of the Post-Traumatic Stress Disorder (PTSD)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Post-Traumatic Stress Disorder (PTSD), complete with comparati …
- スマートヘルスケアソリューションの世界市場:EHR、遠隔医療、mヘルス、スマートピルAbout Smart HealthcareSmart healthcare is the integration of different healthcare delivery mechanisms. It makes use of electronic patient records and streamlining processes, which leads to improved quality of life by reducing the risks to health (by remote monitoring and checks) and improving the general well-being of people. Smart healthcare provides more patient-centric services that improves ac …
- 海上監視の世界市場:用途別(海軍、沿岸警備隊、その他)、構成要素別(レーダー、センサー、AIS受信機、その他)、種類別(監視&追跡、検出器、その他)Maritime surveillance is an integrated solution that provides safety & security at borders and sea levels. Maritime surveillance is essential for creating awareness & real-time monitoring at maritime. The operation or control on the marine activities are traced with the help of various maritime solutions and assemblies. Control on the activities such as irregular migration/border control, maritime …
- ユーカリ精油(エッセンシャルオイル)の世界市場2019-2023About this market The demand for natural products is increasing owing to health concerns among consumers. Consumers are interested in being aware about the ingredients in skin care and food and beverage products, and they are showing an increased preference for natural products. This has increased the demand for eucalyptus essential oil. The emergence of several global and regional food manufactur …
- スポーツ食品及びスポーツ飲料の世界市場2015-2019About Sports Nutrition Sports nutrition products are specially designed to supplement the intake of essential nutrients, to enhance performance, increase physical strength, build muscle, and improve the overall well-being of consumers. Sport nutrition products are useful in supplementing various nutrients such as proteins, vitamins, minerals, carbohydrates, and fats, which help consumers in improv …
- 世界のハイブリッドクラウド市場In todays business environment, organizations strive to meet the constantly changing global business dynamics. Most of the organizations view IT as a tool to be agile and to have a sustainable business success. At the same time, rising IT costs have become a major concern and cost cutting is the current business objective of corporations. Public cloud services have revolutionized the IT industry a …
- モバイルマーケティングソリューションの世界市場:SMS、MMS、プッシュ通知、モバイルEメール、QRコード、モバイルウェブThe mobile marketing market size is expected to grow from USD 28.63 Billion in 2016 to USD 98.85 Billion by 2021, at an estimated Compound Annual Growth Rate (CAGR) of 28.1% during the forecast period. Major growth drivers of the market are increasing number of mobile phone users, high internet speed, and increasing use of mobile web and mobile applications. These factors are expected to shape the …
- 熱伝導性材料の世界市場:ポリマー材料、フェイズチェンジ材、金属材料About TIM TIM is used to support heat sinks in removing heat from heat sources in various equipment. It is generally used in the form of a secondary thermally conducting material to replace the thermally insulating air between the two surfaces. Along with helping in the efficient transfer of heat, TIM also acts as an adhesive and strengthens the mechanical link between the surfaces. Polymer-based …
- パルスオキシメトリの世界市場2017-2021About Pulse Oximetry Pulse oximetry is one of the patient monitoring approaches for the monitoring of oxygen saturation level in the blood. It is a non-invasive method used to measure the arterial blood oxygen saturation level of a patient. This monitoring works on the principle of spectrophotometry and makes use of the pulsating nature of the arterial blood flow and light absorptive characteristi …
- 世界のバンカ油市場2015The Global Bunker Oil Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Bunker Oil industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Bunker Oil market analysis is provided for the international markets including development trends, competitive lands …
- 世界のヘッドマウントディスプレイ市場:Global Head-mounted Displays Market 2014-2018TechNavio's analysts forecast the Global Head-mounted Displays market to grow at a CAGR of 68.2 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing adoption of head-mounted displays in the Consumer Electronics sector. The Global Head-mounted Displays market has also been witnessing the increasing number of augmented reality products. Howev …
- 堅牢型機器の世界市場2017-2021:堅牢型通信装置、堅牢型パソコン、堅牢型ディスプレイAbout Rugged EquipmentMilitary-based rugged equipment follows specific military standards (MIL-STD), while industrial rugged equipment follows ingress protection (IP) grades. IP Code is the international standard used to classify protection against solid objects and water. The IP rating consists of two numbers. The higher the numbers, the more durable the product. The demand for rugged equipment i …
- のぼせ症:治療薬のグローバル治験動向(2014年下半期)Hot Flashes Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Hot Flashes Global Clinical Trials Review, H2, 2014" provides data on the Hot Flashes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hot Flashes. It includes an overview of the trial numbers and their recruitment status as per the site of …